MX2021004383A - Composiciones y metodos para la estimulacion ovarica controlada. - Google Patents
Composiciones y metodos para la estimulacion ovarica controlada.Info
- Publication number
- MX2021004383A MX2021004383A MX2021004383A MX2021004383A MX2021004383A MX 2021004383 A MX2021004383 A MX 2021004383A MX 2021004383 A MX2021004383 A MX 2021004383A MX 2021004383 A MX2021004383 A MX 2021004383A MX 2021004383 A MX2021004383 A MX 2021004383A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- compositions
- ovarian stimulation
- controlled ovarian
- controlled
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pregnancy & Childbirth (AREA)
- Zoology (AREA)
- Gynecology & Obstetrics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se describen métodos que usan y composiciones que incluyen FSH para usarse en el tratamiento de la infertilidad, en los que la dosis se selecciona basándose en la edad de la paciente para optimizar la eficacia acumulativa y/o reducir el riesgo de OHSS.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862746812P | 2018-10-17 | 2018-10-17 | |
EP18203167 | 2018-10-29 | ||
PCT/EP2019/078170 WO2020079127A1 (en) | 2018-10-17 | 2019-10-17 | Compositions and methods for controlled ovarian stimulation |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021004383A true MX2021004383A (es) | 2021-06-04 |
Family
ID=68344788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021004383A MX2021004383A (es) | 2018-10-17 | 2019-10-17 | Composiciones y metodos para la estimulacion ovarica controlada. |
Country Status (17)
Country | Link |
---|---|
US (1) | US20210353717A1 (es) |
EP (1) | EP3866833A1 (es) |
JP (1) | JP2022505191A (es) |
KR (1) | KR20210079276A (es) |
CN (1) | CN112789053A (es) |
AU (1) | AU2019363279A1 (es) |
BR (1) | BR112021005019A2 (es) |
CA (1) | CA3110205A1 (es) |
CL (2) | CL2021000928A1 (es) |
CO (1) | CO2021005872A2 (es) |
IL (1) | IL280750A (es) |
JO (1) | JOP20210025A1 (es) |
MA (1) | MA53909A (es) |
MX (1) | MX2021004383A (es) |
PH (1) | PH12021550417A1 (es) |
SG (1) | SG11202102340RA (es) |
WO (1) | WO2020079127A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL272763B2 (en) | 2017-09-01 | 2024-02-01 | Ferring Bv | The composition for controlled stimulation of the ovary |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003022303A2 (en) * | 2001-09-12 | 2003-03-20 | Applied Research Systems Ars Holding N.V. | Use of hcg and lh in controlled ovarian hyperstimulation |
EP1364658A1 (en) * | 2002-05-24 | 2003-11-26 | Applied Research Systems ARS Holding N.V. | Use of varying ratios of gonadotrophins in controlled ovarian hyperstimulation |
TWI488640B (zh) | 2008-04-16 | 2015-06-21 | Ferring Int Ct Sa | 藥學製劑 |
JO3092B1 (ar) | 2011-08-08 | 2017-03-15 | Ferring Bv | مركب لتحفيز مسيطر عليه للمبيض |
-
2019
- 2019-10-17 CA CA3110205A patent/CA3110205A1/en active Pending
- 2019-10-17 MA MA053909A patent/MA53909A/fr unknown
- 2019-10-17 WO PCT/EP2019/078170 patent/WO2020079127A1/en active Application Filing
- 2019-10-17 KR KR1020217008853A patent/KR20210079276A/ko unknown
- 2019-10-17 CN CN201980064065.3A patent/CN112789053A/zh active Pending
- 2019-10-17 JO JOP/2021/0025A patent/JOP20210025A1/ar unknown
- 2019-10-17 SG SG11202102340RA patent/SG11202102340RA/en unknown
- 2019-10-17 JP JP2021521140A patent/JP2022505191A/ja active Pending
- 2019-10-17 MX MX2021004383A patent/MX2021004383A/es unknown
- 2019-10-17 US US17/285,314 patent/US20210353717A1/en active Pending
- 2019-10-17 AU AU2019363279A patent/AU2019363279A1/en active Pending
- 2019-10-17 BR BR112021005019-1A patent/BR112021005019A2/pt unknown
- 2019-10-17 EP EP19794444.0A patent/EP3866833A1/en active Pending
-
2021
- 2021-02-09 IL IL280750A patent/IL280750A/en unknown
- 2021-02-26 PH PH12021550417A patent/PH12021550417A1/en unknown
- 2021-04-15 CL CL2021000928A patent/CL2021000928A1/es unknown
- 2021-05-04 CO CONC2021/0005872A patent/CO2021005872A2/es unknown
-
2022
- 2022-03-29 CL CL2022000779A patent/CL2022000779A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CL2021000928A1 (es) | 2021-10-22 |
MA53909A (fr) | 2022-01-26 |
WO2020079127A1 (en) | 2020-04-23 |
PH12021550417A1 (en) | 2021-09-20 |
IL280750A (en) | 2021-04-29 |
TW202027780A (zh) | 2020-08-01 |
CO2021005872A2 (es) | 2021-09-20 |
CL2022000779A1 (es) | 2022-11-25 |
CN112789053A (zh) | 2021-05-11 |
JP2022505191A (ja) | 2022-01-14 |
AU2019363279A1 (en) | 2021-03-11 |
CA3110205A1 (en) | 2020-04-23 |
US20210353717A1 (en) | 2021-11-18 |
SG11202102340RA (en) | 2021-05-28 |
KR20210079276A (ko) | 2021-06-29 |
BR112021005019A2 (pt) | 2021-06-08 |
EP3866833A1 (en) | 2021-08-25 |
JOP20210025A1 (ar) | 2021-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SA520412543B1 (ar) | تركيبات وطرائق لعلاج السرطان والاضطرابات المناعية باستخدام جراثيم الفيونيلّة | |
MX2023007212A (es) | Formulaciones de pulverizacion de epinefrina. | |
MX2021005398A (es) | Terapia del cancer con celulas inmunitarias anti-cd33. | |
MX2019009227A (es) | Métodos para tratar cáncer con inhibidores de hsp90. | |
MX2020008680A (es) | Terapia de combinacion con apilimod y agentes glutamatergicos. | |
MX2019009190A (es) | Uso de gaboxadol en el tratamiento de tinnitus. | |
CR20200546A (es) | ESTIMULADOR SELECTIVO TREG RUR20kD-IL-2 Y COMPOSICIONES RELACIONADAS | |
CR20220329A (es) | Anticuerpos anti–mertk y metodos de uso de los mismos | |
ZA201805358B (en) | 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives | |
MX2022006073A (es) | Metodos para utilizar anticuerpos anti-trem2. | |
MX2021013901A (es) | Composiciones y métodos para el tratamiento del cáncer. | |
MX2021005400A (es) | Terapia del cancer con celulas inmunitarias anti-ptk7. | |
JOP20210170A1 (ar) | طرق وتركيبات لعلاج اضطرابات الجلد والشعر | |
MX2023010711A (es) | Fenalquilaminas y métodos de preparación y uso de las mismas. | |
MX2021010665A (es) | Metodos de tratamiento de amiloidosis al. | |
PH12021550417A1 (en) | Compositions and methods for controlled ovarian stimulation | |
PH12021551235A1 (en) | Elacestrant in combination with abemaciclib in women with breast cancer | |
WO2019040105A3 (en) | COMPOUNDS, SALTS THEREOF AND METHODS FOR THE TREATMENT OF DISEASES | |
MX2022005250A (es) | Combinaciones terapeuticas de acalabrutinib y capivasertib para tratar neoplasias malignas de linfocitos b. | |
EA202190891A1 (ru) | Композиции и способы для контролируемой стимуляции яичников | |
MX2021005751A (es) | Anticuerpos contra mucina 16 y métodos de uso de los mismos. | |
WO2019190927A3 (en) | Splice-switching oligonucleotides and methods of use | |
MX2022006883A (es) | Uso de isatuximab para el tratamiento del mieloma multiple recidivante y/o refractario. | |
MD3675894T2 (ro) | Compoziție pentru stimularea ovariană controlată | |
MX2022013895A (es) | Derivados de bexaroteno y su uso en el tratamiento del cancer. |